DMII
Drugs Made In America Acquisition II Corp.Company with tickers: DMII, DMIIR, DMIIU
CIK
2040475
CUSIP
G2851K104
Shares Outstanding
63,700,000
13F Activity (30d)
1 filings
1 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2025-09-26 | Drugs Made In America Acquisition II LLC |
10% Owner | Sell | 7,966,667 |
| 2025-09-26 | Worman Glenn C. |
CFO | Other | 100,000 |
| 2025-09-26 | Stockwell Lynn |
Director, CEO and Exe. Chair of Board, 10% Owner | Other | 400,000 |
| 2025-09-26 | Prasad Sridhar G. |
Director | Other | 100,000 |
| 2025-09-26 | Drugs Made In America Acquisition II LLC |
10% Owner | Buy | 700,000 |
| 2025-09-26 | Do Catherine |
Director | Other | 100,000 |
| 2025-09-26 | Drugs Made In America Acquisition II LLC |
10% Owner | Other | 400,000 |
| 2025-09-26 | Shulgan Myron W. |
Director | Other | 100,000 |
| 2025-09-26 | Stockwell Lynn |
Director, CEO and Exe. Chair of Board, 10% Owner | Buy | 700,000 |
| 2025-09-26 | Stockwell Lynn |
Director, CEO and Exe. Chair of Board, 10% Owner | Buy | 700,000 |
| 2025-09-26 | Drugs Made In America Acquisition II LLC |
10% Owner | Buy | 700,000 |
| 2025-09-26 | Stockwell Lynn |
Director, CEO and Exe. Chair of Board, 10% Owner | Sell | 7,966,667 |
| 2025-09-24 | Prasad Sridhar G. |
Director | Other | 0 |
| 2025-09-24 | Shulgan Myron W. |
Director | Other | 0 |
| 2025-09-24 | Do Catherine |
Director | Other | 0 |
| 2025-09-24 | Worman Glenn C. |
CFO | Other | 0 |
Showing 1–16 of 16 transactions